MedTrace Logo

Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health

NCT02330224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-01-01

No results posted yet for this study

Summary

High blood pressure (BP) is a serious public health problem responsible for heart attack, stroke and kidney failure. One in four adults in Singapore has hypertension. We propose a pilot study in 2 polyclinics in Singapore, 1 deliver a structured multi-component intervention and another usual care. A total of 100 adults with uncontrolled high blood pressure will be followed for 3 months. The intervention includes 1) algorithm-driven antihypertensive treatment for all patients using fixed-dose combination and lipid lowering for high risk patients, 2) motivational conversation for high risk patients; and 3) telephone based follow-ups of all patients by a team of physician supervised nurse practitioners and nurses. The change in BP will be compared between intervention and control groups. The structured care including the above mentioned components is likely to be more effective than usual care in lowering BP levels of patients with uncontrolled high blood pressure. Such a program is also likely to be more cost effective in terms of money spent for improving quality of patients' life. The findings of the pilot will inform the design of a larger cluster randomized trial in eight polyclinics in Singapore. If the main study is successful, the findings will be informative for policymakers to roll out intervention in all polyclinics and primary care centers across Singapore, and other countries with similar healthcare infrastructure.

Conditions

Interventions

OTHER

Hypertension Management Intervention

The multifaceted intervention consists of three main components: 1. Structured treatment algorithm with fixed dose antihypertensives for high cardiovascular disease risk patients 2. Motivational conversation by nurses and nurse practitioners for high risk patients at baseline 3. Telephone based follow-up for all patients by nurses

Sponsors & Collaborators

  • Duke-NUS Graduate Medical School

    lead OTHER

Principal Investigators

  • Tazeen H Jafar, MD, MPH · Duke-NUS Graduate Medical School

  • Ngiap Chuan Tan, MBBS · SingHealth Polyclinics, Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02330224 on ClinicalTrials.gov